Adicet Bio, Inc. ACET
9.02
0.75
9.07%
as of 25 Sep
- Market cap
- $77.4M
- P/E
- 0.0×
Follow ACET
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
5.44 | 7.36 | 7.52 | 6.57 | |
Current Ratio |
5.62 | 7.47 | 7.66 | 6.71 | |
Net Debt/EBITDA |
3.78 | 5.00 | 6.51 | 5.41 | |
Debt/Assets |
0.45% | 0.33% | 0.51% | 0.42% | |
Debt/Equity |
0.01 | 0.00 | 0.01 | 0.01 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.83 | 0.69 | 1.06 | 0.93 | |
Capex/Depreciation |
(0.24) | 0.03 | (0.07) | (0.36) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.92) | (3.03) | (2.00) | (1.84) | |
Capex per Share |
(0.04) | 0.00 | 0.00 | (0.02) | |
Free Cash Flow per Share |
(3.96) | (3.03) | (2.00) | (1.86) | |
Cash per Share |
18.11 | 23.00 | 12.81 | 11.00 | |
Shareholders Equity per Share |
19.17 | 23.10 | 13.04 | 11.18 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.17 | 23.10 | 13.04 | 11.18 | |
Free Cash Flow |
(22.52) | (20.90) | (21.53) | (20.02) | |
Working Capital |
87.55 | 139.40 | 121.77 | 102.76 | |
Capital Expenditures |
(0.21) | 0.01 | (0.04) | (0.20) | |
Net Current Asset Value |
75.16 | 127.78 | 110.75 | 92.74 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
3.39 | 4.78 | 3.67 | 3.44 | |
Average Assets |
193.22 | 206.29 | 180.33 | 155.57 | |
Average Common Equity |
160.34 | 172.91 | 150.76 | 126.76 |
Columns are period end dates